Pritesh Shah
No más puestos en curso
Fortuna: 3 M $ al 31/05/2024
Perfil
Pritesh Shah worked as a Marketing Director for the Oncology Pipeline at OSI Pharmaceuticals, Inc. He then served as the Chief Growth Officer at NovoCure Ltd.
from 2022 to 2024.
Dr. Shah holds a graduate degree from Seton Hall University and a doctorate from the University of Maryland.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NOVOCURE LTD.
0.11% | 02/04/2024 | 119 794 ( 0.11% ) | 3 M $ | 31/05/2024 |
Antiguos cargos conocidos de Pritesh Shah.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVOCURE LIMITED | Corporate Officer/Principal | 01/01/2024 |
| OSI PHARMACEUTICALS, INC. | Ventas & Marketing | - |
Formación de Pritesh Shah.
| University of Maryland | Doctorate Degree |
| Seton Hall University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NOVOCURE LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Pritesh Shah
